Clene Inc.

NASDAQ:CLNN

Biotechnology

Healthcare
$3.50 +1.35%

+$0.08 today

Market cap
$50.40M
Beta
0.92
P/E (TTM)
-2.1
EPS (TTM)
-$2.88
52W Low $3.25High $13.50

Volume 0.12M

Average 0.50M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$18.55M

FY 2025 · Annual

Investing Cash Flow

-$39,000.00

FY 2025 · Annual

Financing Cash Flow

$11.52M

FY 2025 · Annual

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(9.74M)(29.92M)(49.5M)(39.4M)(26.17M)
Depreciation & Amortization955K1.02M1.71M1.65M1.5M
Deferred Income Tax00000
Stock-Based Compensation12.38M8.51M9.12M7.95M6.38M
Change in Working Capital1M(1.54M)(191K)3.21M(3.35M)
Accounts Receivables(28K)(140K)46K79K64K
Inventory150K(2K)6K(31K)31K
Accounts Payables1.27M285K(1.51M)(264K)(348K)
Other Working Capital(386K)(1.68M)1.27M3.43M(3.1M)
Other Non-Cash Items(39.23M)(17.09M)8.7M5.27M3.1M
Operating Cash Flow(34.62M)(39.01M)(30.17M)(21.33M)(18.55M)
Capital Expenditures(1.33M)(5.18M)(330K)(15K)(39K)
Acquisitions (Net)00000
Purchases of Investments0(24.61M)(6.17M)(6.17M)0
Sales of Investments019.63M5M12.5M0
Other Investing Activities00000
Investing Cash Flow(1.33M)(10.16M)(1.5M)6.32M(39K)
Debt Repayment19.84M5.56M269K(10.9M)1.12M
Common Stock Issued9.25M11.46M42.09M9.24M10.4M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(1.98M)229K(200K)124K0
Financing Cash Flow27.11M17.25M42.16M(1.53M)11.52M
Effect of Forex Changes(85K)(30K)(4K)(127K)101K
Net Change in Cash(8.93M)(31.96M)10.49M(16.67M)(6.97M)
Free Cash Flow(35.96M)(44.19M)(30.5M)(21.34M)(18.59M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$26.2M
+ D&A$1.5M
+ Stock-Based Comp$6.4M
+ Deferred Tax$0
- Working Capital-$3.4M
+ Other Non-Cash$3.1M
= Operating Cash Flow-$18.5M
- Capex-$39.0K
= Free Cash Flow-$18.6M

Analysis

FY2025 free cash flow is -$18.6M. FCF conversion is 71.0% of net income. Operating cash flow was -$18.5M, with capex of -$39.0K. The largest bridge item is Stock-Based Comp at $6.4M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 4, 2026
10-QQuarterly reportNov 4, 2026
4Statement of changes in beneficial ownershipOct 21, 2026
4Statement of changes in beneficial ownershipOct 21, 2026
4Statement of changes in beneficial ownershipOct 21, 2026

Does CLNN generate free cash flow?

Clene Inc. (CLNN) generated -$18.59M of free cash flow in fiscal 2025.

How much operating cash flow does CLNN produce?

Operating cash flow was -$18.55M, before capital expenditures of $39,000.00.